查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595191

胰臟癌治療市場：依受影響地區、類型分類 - 全球預測 2025-2030

Pancreatic Cancer Treatment Market by Affected region (Endocrine, Exocrine), Type (Chemotherapy, Targeted Therapy) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年胰臟癌治療市場價值為28.6億美元，預計到2024年將達到32.3億美元，複合年成長率為13.31%，預計到2030年將達到68.5億美元。

胰臟癌治療市場範圍包括手術、化療、放射線治療和新興免疫療法等多種治療方法。這些治療的需求是由於胰臟癌的侵襲性和預後不良，因此需要及時的醫療介入。其應用範圍從早期患者的手術切除到晚期的姑息治療。最終用戶包括醫院、癌症研究中心、專科診所等。市場成長受到胰臟癌發病率上升、診斷影像技術的進步以及分子分析技術的進步導致個人化醫療的影響。不斷增加的政府和非政府癌症治療舉措也推動了市場擴張。然而，早期無症狀導致診斷延遲、晚期治療效果有限、治療費用高昂是主要問題。這種疾病生物學的複雜性使有效治療方法的發展變得更加複雜。隨著將新藥物整合到現有治療方案中的聯合治療的出現以及擴大使用奈米技術來更有效地提供治療，現代治療機會正在出現。此外，對早期檢測方法和生物標記的關注將徹底改變診斷空間並促進更有效的治療計劃。創新研究領域包括開發更複雜的基因療法、利用人工智慧進行精確的個人化治療以及探索腫瘤微環境在抗治療性中的作用。儘管面臨挑戰，胰臟癌治療市場仍在大力投資研發，以改善患者的治療效果，這反映了其動態和快速發展的本質。為了利用這些機會，相關人員需要與生物技術公司建立合作夥伴關係進行早期臨床試驗，投資最尖端科技以加強治療服務，並改善患者經濟狀況。這些行動使公司能夠在醫療需求未被滿足的複雜領域中取得成功。

主要市場統計
基準年[2023] 28.6億美元
預測年份 [2024] 32.3億美元
預測年份 [2030] 68.5億美元
複合年成長率（%） 13.31%

市場動態：快速發展的胰臟癌治療市場的關鍵市場洞察

供需的動態交互作用正在改變胰臟癌治療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 老年人口增加和癌症盛行率增加
    • 不健康習慣增加，例如菸草消費和吸煙
    • 提高對各種可用癌症治療方法的認知
  • 市場限制因素
    • 缺乏負擔得起且高效的及時診斷技術
  • 市場機會
    • 持續的技術進步
    • 對微創治療的需求不斷成長
  • 市場挑戰
    • 治療相關的副作用

波特五力：駕馭胰臟癌治療市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解胰臟癌治療市場的外部影響

外部宏觀環境因素在塑造胰臟癌治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解胰臟癌治療市場的競爭狀況

對胰臟癌治療市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣胰臟癌治療市場供應商績效評估

FPNV定位矩陣是評估胰臟癌治療市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了胰臟癌治療市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對胰臟癌治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 老年人口增加和癌症發生率增加
      • 不健康習慣增加，例如菸草消費和吸煙
      • 提高對各種可用癌症治療方法的認知
    • 抑制因素
      • 缺乏可負擔且有效率的及時診斷技術
    • 機會
      • 持續的技術進步
      • 微創手術需求增加
    • 任務
      • 治療相關的副作用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 受影響地區胰臟癌治療市場

  • 內分泌
  • 外分泌

第7章胰臟癌治療市場：依類型

  • 化療
  • 標靶治療

第8章美洲胰臟癌治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區胰臟癌治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的胰臟癌治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbvie Inc.
  • Amgen Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Clovis Oncology, Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • FUJIFILM Holdings Corporation
  • Hetero Healthcare Limited
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-AD36CD897DAF

The Pancreatic Cancer Treatment Market was valued at USD 2.86 billion in 2023, expected to reach USD 3.23 billion in 2024, and is projected to grow at a CAGR of 13.31%, to USD 6.85 billion by 2030.

The scope of the pancreatic cancer treatment market includes various therapeutic approaches like surgery, chemotherapy, radiation therapy, and emerging immunotherapies. The necessity of these treatments is driven by pancreatic cancer's aggressive nature and poor prognosis, mandating immediate medical intervention. Applications span from surgical resection for early-stage patients to palliative care for advanced stages. End-users include hospitals, cancer research centers, and specialty clinics. Market growth is influenced by rising pancreatic cancer incidence, technological advancements in diagnostic imaging, and improved molecular profiling leading to personalized medicines. Increasing government and non-government initiatives for cancer treatment also boost market expansion. However, late diagnosis due to asymptomatic early stages, limited efficacy of treatments for advanced stages, and high treatment costs pose significant challenges. The complexity of the disease's biology further complicates the development of effective therapies. Latest opportunities emerge in the advent of combination therapies that integrate novel drugs with existing treatment protocols and the increasing use of nanotechnology to deliver treatments more efficiently. Additionally, the emphasis on early detection methods and biomarkers innovates the diagnostic area, fostering more effective treatment planning. Innovative research areas include developing more refined gene therapies, leveraging artificial intelligence for precise treatment personalization, and exploring the role of the tumor microenvironment in treatment resistance. Despite its challenges, the pancreatic cancer treatment market is heavily investing in R&D for improved patient outcomes, reflecting its dynamic and rapidly evolving nature. To capitalize on these opportunities, stakeholders should focus on forging collaborations with biotech firms for early-phase trials, investing in cutting-edge technology to enhance treatment delivery, and advocating for policy changes that lower financial barriers for patients. These actions can enable companies to thrive in a complex field with significant unmet medical needs.

KEY MARKET STATISTICS
Base Year [2023] USD 2.86 billion
Estimated Year [2024] USD 3.23 billion
Forecast Year [2030] USD 6.85 billion
CAGR (%) 13.31%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pancreatic Cancer Treatment Market

The Pancreatic Cancer Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising geriatric population and increasing prevalence of cancer
    • Increasing unhealthy habits such as tobacco consumption and smoking
    • Growing awareness about various available cancer treatments
  • Market Restraints
    • Unavailability of affordable and efficient technologies for timely diagnosis
  • Market Opportunities
    • Continuous technological advancements
    • Rising demand for minimally invasive procedures
  • Market Challenges
    • Side effects related to treatment

Porter's Five Forces: A Strategic Tool for Navigating the Pancreatic Cancer Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pancreatic Cancer Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pancreatic Cancer Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pancreatic Cancer Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pancreatic Cancer Treatment Market

A detailed market share analysis in the Pancreatic Cancer Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pancreatic Cancer Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pancreatic Cancer Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pancreatic Cancer Treatment Market

A strategic analysis of the Pancreatic Cancer Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pancreatic Cancer Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbvie Inc., Amgen Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Clovis Oncology, Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., FUJIFILM Holdings Corporation, Hetero Healthcare Limited, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Pfizer, Inc., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Pancreatic Cancer Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Affected region, market is studied across Endocrine and Exocrine.
  • Based on Type, market is studied across Chemotherapy and Targeted Therapy.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising geriatric population and increasing prevalence of cancer
      • 5.1.1.2. Increasing unhealthy habits such as tobacco consumption and smoking
      • 5.1.1.3. Growing awareness about various available cancer treatments
    • 5.1.2. Restraints
      • 5.1.2.1. Unavailability of affordable and efficient technologies for timely diagnosis
    • 5.1.3. Opportunities
      • 5.1.3.1. Continuous technological advancements
      • 5.1.3.2. Rising demand for minimally invasive procedures
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects related to treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pancreatic Cancer Treatment Market, by Affected region

  • 6.1. Introduction
  • 6.2. Endocrine
  • 6.3. Exocrine

7. Pancreatic Cancer Treatment Market, by Type

  • 7.1. Introduction
  • 7.2. Chemotherapy
  • 7.3. Targeted Therapy

8. Americas Pancreatic Cancer Treatment Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Pancreatic Cancer Treatment Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Pancreatic Cancer Treatment Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbvie Inc.
  • 2. Amgen Inc.
  • 3. Astellas Pharma Inc.
  • 4. AstraZeneca PLC
  • 5. Bristol-Myers Squibb Company
  • 6. Clovis Oncology, Inc.
  • 7. Eli Lilly and Company
  • 8. F. Hoffmann-La Roche Ltd.
  • 9. FUJIFILM Holdings Corporation
  • 10. Hetero Healthcare Limited
  • 11. Johnson & Johnson Services, Inc.
  • 12. Merck & Co., Inc.
  • 13. Novartis AG
  • 14. Pfizer, Inc.
  • 15. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. PANCREATIC CANCER TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. PANCREATIC CANCER TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PANCREATIC CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PANCREATIC CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PANCREATIC CANCER TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PANCREATIC CANCER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PANCREATIC CANCER TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PANCREATIC CANCER TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY ENDOCRINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY EXOCRINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC PANCREATIC CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM PANCREATIC CANCER TREATMENT MARKET SIZE, BY AFFECTED REGION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM PANCREATIC CANCER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. PANCREATIC CANCER TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. PANCREATIC CANCER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023